These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A model for the observer on the Farnsworth-Munsell 100-hue test. Craven BJ. Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):507-11. PubMed ID: 8449670 [Abstract] [Full Text] [Related]
4. Comparison of the Richmond HRR 4th edition and Farnsworth-Munsell 100 Hue Test for quantitative assessment of tritan color deficiencies. Foote KG, Neitz M, Neitz J. J Opt Soc Am A Opt Image Sci Vis; 2014 Apr 01; 31(4):A186-8. PubMed ID: 24695168 [Abstract] [Full Text] [Related]
5. Glaucoma, lighting and color vision. An investigation into their interrelationship. Nuzzi R, Bellan A, Boles-Carenini B. Ophthalmologica; 1997 Apr 01; 211(1):25-31. PubMed ID: 8958528 [Abstract] [Full Text] [Related]
6. Comparison of the Farnsworth-Munsell 100-Hue, the Farnsworth D-15, and the L'Anthony D-15 desaturated color tests. Bassi CJ, Galanis JC, Hoffman J. Arch Ophthalmol; 1993 May 01; 111(5):639-41. PubMed ID: 8489445 [Abstract] [Full Text] [Related]
10. End-box scoring artefact evaluation of the Farnsworth-Munsell 100-Hue colour vision test. Viliūnas V, Lukauskiene R, Svegzda A, Zukauskas A. Ophthalmic Physiol Opt; 2006 Nov 01; 26(6):580-6. PubMed ID: 17040422 [Abstract] [Full Text] [Related]
11. Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations. Bertrand JA, Bedetti C, Postuma RB, Monchi O, Génier Marchand D, Jubault T, Gagnon JF. Mov Disord; 2012 Dec 01; 27(14):1781-8. PubMed ID: 23147270 [Abstract] [Full Text] [Related]
12. Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy. Nousiainen I, Kälviäinen R, Mäntyjärvi M. Ophthalmology; 2000 May 01; 107(5):884-8. PubMed ID: 10811079 [Abstract] [Full Text] [Related]
13. Adverse consequences of altering the Farnsworth-Munsell 100-Hue test. Applegate RA, Trick LR. Am J Optom Physiol Opt; 1985 Apr 01; 62(4):265-74. PubMed ID: 3873177 [Abstract] [Full Text] [Related]
14. An averaging method for the interpretation of the Farnsworth-Munsell 100-Hue Test--I. Congenital colour vision defects. Dain SJ, Birch J. Ophthalmic Physiol Opt; 1987 Apr 01; 7(3):267-80. PubMed ID: 3500446 [Abstract] [Full Text] [Related]
15. Technical note: the effect of refractive blur on colour vision evaluated using the Cambridge Colour Test, the Ishihara Pseudoisochromatic Plates and the Farnsworth Munsell 100 Hue Test. Thyagarajan S, Moradi P, Membrey L, Alistair D, Laidlaw H. Ophthalmic Physiol Opt; 2007 May 01; 27(3):315-9. PubMed ID: 17470246 [Abstract] [Full Text] [Related]
16. Hue discrimination and S cone pathway sensitivity in early diabetic retinopathy. Greenstein V, Sarter B, Hood D, Noble K, Carr R. Invest Ophthalmol Vis Sci; 1990 Jun 01; 31(6):1008-14. PubMed ID: 2354907 [Abstract] [Full Text] [Related]
17. A new computer-based Farnsworth Munsell 100-hue test for evaluation of color vision. Ghose S, Parmar T, Dada T, Vanathi M, Sharma S. Int Ophthalmol; 2014 Aug 01; 34(4):747-51. PubMed ID: 24097078 [Abstract] [Full Text] [Related]
18. The use of colour difference vectors in diagnosing congenital colour vision deficiencies with the Farnsworth-Munsell 100-hue test. Vingrys AJ, Atchison DA, Bowman KJ. Ophthalmic Physiol Opt; 1992 Jan 01; 12(1):38-45. PubMed ID: 1584615 [Abstract] [Full Text] [Related]
19. Color-axis determination on the Farnsworth-Munsell 100-hue test. Smith VC, Pokorny J, Pass AS. Am J Ophthalmol; 1985 Jul 15; 100(1):176-82. PubMed ID: 3874549 [Abstract] [Full Text] [Related]
20. Normal test scores in the Farnsworth-Munsell 100 hue test. Mantyjarvi M. Doc Ophthalmol; 2001 Jan 15; 102(1):73-80. PubMed ID: 11475367 [Abstract] [Full Text] [Related] Page: [Next] [New Search]